Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2014 Nov;18(6):874-5.
doi: 10.4103/2230-8210.141397.

Sodium glucose co transporter 2 inhibitors and Ramadan: Another string to the bow

Affiliations

Sodium glucose co transporter 2 inhibitors and Ramadan: Another string to the bow

Jayant Kelwade et al. Indian J Endocrinol Metab. 2014 Nov.
No abstract available

PubMed Disclaimer

References

    1. Salti I, Bénard E, Detournay B, Bianchi-Biscay M, Le Brigand C, Voinet C, et al. A population-based study of diabetes and its characteristics during the fasting month of Ramadan in 13 countries: Results of the epidemiology of diabetes and Ramadan 1422/2001 (EPIDIAR) study. Diabetes Care. 2004;27:2306–11. - PubMed
    1. Casablanca, Morocco: FRSMR; 1995. International Meeting on Diabetes and Ramadan Recommendations.Edition of the Hassan II Foundation for Scientific and Medical Research on Ramadan.
    1. Pan C, Yang W, Barona JP, Wang Y, Niggli M, Mohideen P, et al. Comparison of vildagliptin and acarbose monotherapy in patients with type 2 diabetes: A 24-week, double-blind, randomized trial. Diabet Med. 2008;25:435–41. - PubMed
    1. Devendra D, Gohel B, Bravis V, Hui E, Salih S, Mehar S, et al. Vildagliptin therapy and hypoglycaemia in Muslim type 2 diabetes patients during Ramadan. Int J Clin Pract. 2009;63:1446–50. - PubMed
    1. Bashir MI, Pathan MF, Raza SA, Ahmad J, Khan AK, Ishtiaq O, et al. Role of oral hypoglycemic agents in the management of type 2 diabetes mellitus during Ramadan. Indian J Endocrinol Metab. 2012;16:503–7. - PMC - PubMed